Shaoyao Decoction Inhibits Colorectal Cancer Progression by Targeting PD-L1 to Reprogram the Immunosuppressive Tumor Microenvironment
Applied Biochemistry and Biotechnology · 2026-12 · 198 (12) · 11110-11130
DOI: 10.1007/s12010-026-05926-0 ↗At a glance
Journal article in Applied Biochemistry and Biotechnology, published online on 2026-09-18. Written by Xiaoyan Wang and 4 co-authors. Institution: Hospital Office, Wangjing Hospital, China Academy of Chinese Medical Sciences, Chaoyang District, Beijing, 100102, China. Major MEDLINE topics: Colorectal Neoplasms, B7-H1 Antigen, Tumor Microenvironment, Drugs, Chinese Herbal. 34 references. Funded by: Fundamental Research Funds for the Central Public Welfare Research Institutes, Key Program of Tibet Autonomous Region Natural Science Foundation, National Natural Science Foundation of China.
Abstract (original language)
Colorectal cancer (CRC), particularly the microsatellite-stable (MSS) subtype accounting for ~ 85% of cases, remains refractory to immune checkpoint inhibitors due to persistent immunosuppression. Shaoyao Decoction (SYD), a traditional Chinese herbal formula, is known for its anti-inflammatory and anticancer effects. However, the mechanisms by which it modulates immune responses in colorectal cancer (CRC) remain poorly understood. Here, we evaluated SYD's efficacy in AOM/DSS-induced colitis-associated CRC and PD-L1-overexpressing MC38 syngeneic models, using the PD-1/PD-L1 inhibitor BMS-202 as a positive control. In vivo, SYD significantly suppressed tumor growth, normalized colon structure, and reduced tumor burden, with efficacy comparable to BMS-202 but without overt toxicity. Mechanistically, SYD downregulated PD-L1 expression in tumor and spleen tissues, shifted serum cytokines toward a pro-inflammatory profile characterized by increased IL-2 and IFN-γ as well as decreased IL-10 and TGF-β, and restored CD4⁺/CD8⁺ T cell balance. In vitro, SYD inhibited the viability of PD-L1-overexpressing MC38 cells and reduced PD-L1 mRNA expression. Collectively, SYD exerts potent anti-CRC effects by targeting PD-L1 to remodel the immunosuppressive tumor microenvironment. As a multi-target agent, it holds great promise for MSS-CRC, bridging TCM with modern immuno-oncology.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hospital Office, Wangjing Hospital, China Academy of Chinese Medical Sciences, Chaoyang District, Beijing, 100102, China.
- Xizang Autonomous Region Tibetan Medicine Hospital, Tibet Autonomous Region, Chengguan District, Lhasa, 850002, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Dongcheng District, Beijing, 100700, China.
- Hospital Office, Wangjing Hospital, China Academy of Chinese Medical Sciences, Chaoyang District, Beijing, 100102, China. wjhplihao1965@126.com.
Funding
- Fundamental Research Funds for the Central Public Welfare Research Institutes
- Key Program of Tibet Autonomous Region Natural Science Foundation
- National Natural Science Foundation of China
- Key Research and Development Program of Xizang Autonomous Region Science and Technology Plan Projects
Cite
APA
Wang, X., Mima, Z., Sai, W., Song, L., & Li, H. (2026). Shaoyao Decoction Inhibits Colorectal Cancer Progression by Targeting PD-L1 to Reprogram the Immunosuppressive Tumor Microenvironment. Applied Biochemistry and Biotechnology, 198(12), 11110-11130. https://doi.org/10.1007/s12010-026-05926-0
Vancouver
Wang X, Mima Z, Sai W, Song L, Li H. Shaoyao Decoction Inhibits Colorectal Cancer Progression by Targeting PD-L1 to Reprogram the Immunosuppressive Tumor Microenvironment. Applied Biochemistry and Biotechnology. 2026;198(12):11110-11130. doi:10.1007/s12010-026-05926-0
BibTeX
@article{Wang2026,
author = {Wang, Xiaoyan and Mima, Zhuoga and Sai, Wujie and Song, Lijuan and Li, Hao},
title = {Shaoyao Decoction Inhibits Colorectal Cancer Progression by Targeting PD-L1 to Reprogram the Immunosuppressive Tumor Microenvironment},
journal = {Applied Biochemistry and Biotechnology},
year = {2026},
volume = {198},
number = {12},
pages = {11110--11130},
doi = {10.1007/s12010-026-05926-0}
}
EUVIMED